These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 123599)

  • 21. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunodepression in trypanosome-infected mice. VI. Comparison of immune responses of different lymphoid organs.
    Kar SK; Roelants GE; Mayor-Withey KS; Pearson TW
    Eur J Immunol; 1981 Feb; 11(2):100-5. PubMed ID: 6452282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro stimulation of murine lymphoid cell cultures by levamisole.
    Merluzzi VJ; Badger AM; Kaiser CW; Cooperband SR
    Clin Exp Immunol; 1975 Dec; 22(3):486-92. PubMed ID: 1083786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
    Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
    Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory action of THF on T-cell reactivity to mitogens.
    Gabizon A; Trainin N
    Thymus; 1980 Jan; 1(4-5):225-39. PubMed ID: 6969474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of NK cell activation: relationship between Qa5+ NK cells and lymphocytes.
    Chun M; Fernandes G; Hoffmann MK
    J Immunol; 1981 Jan; 126(1):331-4. PubMed ID: 7451974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoid cell subpopulations. I. Synergy between lymph node cells and thymocytes in response to alloantigens and mitogens.
    Howe ML; Cohen L
    J Immunol; 1975 Nov; 115(5):1227-32. PubMed ID: 51885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of the Bcg gene. II. Genetic restriction of responses to mitogens and allogeneic targets.
    Denis M; Buschman E; Forget A; Pelletier M; Skamene E
    J Immunol; 1988 Dec; 141(11):3988-93. PubMed ID: 2972781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble suppressor factor from the spleens of tumor-bearing mice.
    Subramanian C; Yu S; McKhann CF
    Cancer Res; 1978 Jul; 38(7):1996-2002. PubMed ID: 657137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-1 stimulation of lymphopoiesis.
    Clark R; Strasser J; McCabe S; Robbins K; Jardieu P
    J Clin Invest; 1993 Aug; 92(2):540-8. PubMed ID: 8349796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of complement receptor-bearing cells in the spleens of tumor-bearing mice.
    Epstein RS; Lopez DM; Sigel MM; Ross GD
    J Immunol; 1978 Oct; 121(4):1524-7. PubMed ID: 308966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.
    Levy JG; McMaster R; Kelly B; Whitney RB; Kilburn DG
    Immunology; 1977 Apr; 32(4):475-81. PubMed ID: 305409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ultraviolet irradiation on the localization of syngeneic and allogeneic lymphoid cells and on alloimmunogenicity.
    Milton JD
    Immunology; 1981 Oct; 44(2):281-7. PubMed ID: 7298068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
    Kumar V; Bennett M
    J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of mitogen-induced blastogenesis by the Trypanosoma cruzi-induced suppressor substance.
    Cunningham DS; Benavides GR; Kuhn RE
    J Parasitol; 1980 Oct; 66(5):722-9. PubMed ID: 6780676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
    Fu YX; Watson GA; Kasahara M; Lopez DM
    J Immunol; 1991 Jan; 146(2):783-9. PubMed ID: 1824777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T and B lymphocyte migration into syngeneic tumors.
    Elboim CM; Reinisch CL; Schlossman SF
    J Immunol; 1977 Mar; 118(3):1042-8. PubMed ID: 300384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.